Clareon, the intraocular lens (IOL)is to be launched at European Society of Cataract & Refractive Surgeons (ESCRS) congress.-Alcon/Novartis.
Alcon, the global leader in eye care and a division of Novartis, will introduce Clareon, the intraocular lens (IOL) with the most advanced optic material available in an automated, disposable, pre-loaded delivery system, at the XXXV European Society of Cataract & Refractive Surgeons (ESCRS) congress taking place October 7 � 11 in Lisbon, Portugal.
Alcon Cataract Symposium � Clareon IOL: A new IOL Platform - Moderated by Prof. Rudy Nuijts (1:00 � 2:00 p.m., Room 4.7, FIL congress center).
Alcon�s Clareon monofocal IOL has gained CE mark approval in the European Union.Novartis has described Clareon as Alcon�s next-generation polymer material that maintains the benefits of Alcon�s AcrySof platform, including refractive and rotational stability, unfolding characteristics, improved visual outcomes, and a reduction in glistenings and surface haze. Novartis hopes to get US approval of the Clareon by 2019.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.